BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 30059005)

  • 1. An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer.
    Li J; Choi PS; Chaffer CL; Labella K; Hwang JH; Giacomelli AO; Kim JW; Ilic N; Doench JG; Ly SH; Dai C; Hagel K; Hong AL; Gjoerup O; Goel S; Ge JY; Root DE; Zhao JJ; Brooks AN; Weinberg RA; Hahn WC
    Elife; 2018 Jul; 7():. PubMed ID: 30059005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combinatorially regulated RNA splicing signature predicts breast cancer EMT states and patient survival.
    Qiu Y; Lyu J; Dunlap M; Harvey SE; Cheng C
    RNA; 2020 Sep; 26(9):1257-1267. PubMed ID: 32467311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.
    Harvey SE; Xu Y; Lin X; Gao XD; Qiu Y; Ahn J; Xiao X; Cheng C
    RNA; 2018 Oct; 24(10):1326-1338. PubMed ID: 30042172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
    Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype.
    Shapiro IM; Cheng AW; Flytzanis NC; Balsamo M; Condeelis JS; Oktay MH; Burge CB; Gertler FB
    PLoS Genet; 2011 Aug; 7(8):e1002218. PubMed ID: 21876675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β.
    Tripathi V; Sixt KM; Gao S; Xu X; Huang J; Weigert R; Zhou M; Zhang YE
    Mol Cell; 2016 Nov; 64(3):549-564. PubMed ID: 27746021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin.
    Tanaka I; Chakraborty A; Saulnier O; Benoit-Pilven C; Vacher S; Labiod D; Lam EWF; Bièche I; Delattre O; Pouzoulet F; Auboeuf D; Vagner S; Dutertre M
    Nucleic Acids Res; 2020 Mar; 48(5):2676-2693. PubMed ID: 31943118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing.
    Hu X; Harvey SE; Zheng R; Lyu J; Grzeskowiak CL; Powell E; Piwnica-Worms H; Scott KL; Cheng C
    Nat Commun; 2020 Jan; 11(1):486. PubMed ID: 31980632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing.
    Xu Y; Gao XD; Lee JH; Huang H; Tan H; Ahn J; Reinke LM; Peter ME; Feng Y; Gius D; Siziopikou KP; Peng J; Xiao X; Cheng C
    Genes Dev; 2014 Jun; 28(11):1191-203. PubMed ID: 24840202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression.
    Grelet S; Link LA; Howley B; Obellianne C; Palanisamy V; Gangaraju VK; Diehl JA; Howe PH
    Nat Cell Biol; 2017 Sep; 19(9):1105-1115. PubMed ID: 28825698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles and Regulation of Epithelial Splicing Regulatory Proteins 1 and 2 in Epithelial-Mesenchymal Transition.
    Göttgens EL; Span PN; Zegers MM
    Int Rev Cell Mol Biol; 2016; 327():163-194. PubMed ID: 27692175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors.
    Di Modugno F; Iapicca P; Boudreau A; Mottolese M; Terrenato I; Perracchio L; Carstens RP; Santoni A; Bissell MJ; Nisticò P
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19280-5. PubMed ID: 23129656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state.
    Katz Y; Li F; Lambert NJ; Sokol ES; Tam WL; Cheng AW; Airoldi EM; Lengner CJ; Gupta PB; Yu Z; Jaenisch R; Burge CB
    Elife; 2014 Nov; 3():e03915. PubMed ID: 25380226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells.
    Ma HR; Cao L; Wang F; Cheng C; Jiang R; Zhou H; Xie Z; Wuermanbieke S; Qian Z
    Oncol Rep; 2020 May; 43(5):1536-1546. PubMed ID: 32323860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
    Roy Burman D; Das S; Das C; Bhattacharya R
    Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking.
    Pillman KA; Phillips CA; Roslan S; Toubia J; Dredge BK; Bert AG; Lumb R; Neumann DP; Li X; Conn SJ; Liu D; Bracken CP; Lawrence DM; Stylianou N; Schreiber AW; Tilley WD; Hollier BG; Khew-Goodall Y; Selth LA; Goodall GJ; Gregory PA
    EMBO J; 2018 Jul; 37(13):. PubMed ID: 29871889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer.
    Fici P; Gallerani G; Morel AP; Mercatali L; Ibrahim T; Scarpi E; Amadori D; Puisieux A; Rigaud M; Fabbri F
    Oncotarget; 2017 Jan; 8(2):2423-2436. PubMed ID: 27911856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.
    Bhattacharya R; Mitra T; Ray Chaudhuri S; Roy SS
    J Cell Biochem; 2018 Apr; 119(4):3373-3383. PubMed ID: 29130517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quaking isoforms cooperate to promote the mesenchymal phenotype.
    Neumann DP; Phillips CA; Lumb R; Palethorpe HM; Ramani Y; Hollier BG; Selth LA; Bracken CP; Goodall GJ; Gregory PA
    Mol Biol Cell; 2024 Feb; 35(2):ar17. PubMed ID: 38019605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells.
    Chang JG; Yang DM; Chang WH; Chow LP; Chan WL; Lin HH; Huang HD; Chang YS; Hung CH; Yang WK
    PLoS One; 2011; 6(6):e18643. PubMed ID: 21694768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.